Propensity-Score-Matching Sleeve Gastrectomy vs. Gastric Bypass with 3 Years of Follow-Up

  title={Propensity-Score-Matching Sleeve Gastrectomy vs. Gastric Bypass with 3 Years of Follow-Up},
  author={Hartmann Lisa and Christine Stroh and Frank Benedix and Stefanie Wolff and Martin Hukauf},
Background: From 1 January 2005, cases of bariatric surgery were examined with the help of the Quality Assurance Study for operative medicine. All data were registered and analyzed prospectively in cooperation with the Institute of Quality Assurance in Surgery at the Otto-von-Guericke University Magdeburg, Germany. The focus of the comparative study is on perioperative morbidity and complications. Methods: Data collection includes people of full age who underwent Sleeve Gastrectomy or Gastric… 

Tables from this paper


Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass. Data from IFSO-European Chapter Center of Excellence Program
Both procedures were performed with very low complications, mortality, readmissions, and reoperations rate, and better weight loss was observed following RYGBP, the first five postoperative years.
Laparoscopic Sleeve Gastrectomy Versus Roux-Y-Gastric Bypass for Morbid Obesity—3-Year Outcomes of the Prospective Randomized Swiss Multicenter Bypass Or Sleeve Study (SM-BOSS)
LSG and LRYGB are equally efficient regarding weight loss, quality of life, and complications up to 3 years postsurgery, and Quality of life increased significantly in both groups after 1, 2, and 3 years posturgery.
Are There Gender-Specific Aspects in Obesity and Metabolic Surgery? Data Analysis from the German Bariatric Surgery Registry
Metabolic and obesity surgery is becoming more and more popular in Germany, and data from the GBSR study show significant differences in preoperative comorbidities and postoperative complication and mortality rates between male and female patients.
Long-term follow-up after sleeve gastrectomy versus Roux-en-Y gastric bypass versus one-anastomosis gastric bypass: a prospective randomized comparative study of weight loss and remission of comorbidities
OAGB achieves superior mid- and long-term weight loss than RYGB and SG, and achieves better short-and-long-term resolution rates of DM, HT, and DL than SG and RyGB.
Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial
Among patients with morbid obesity, there was no significant difference in excess BMI loss between Laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass at 5 years of follow-up after surgery.
Early Results of the Swiss Multicentre Bypass or Sleeve Study (SM-BOSS)
LSG was associated with shorter operation time and a trend toward fewer complications than with LRYGB, and both procedures were almost equally efficient regarding weight loss, improvement of comorbidities, and quality of life 1 year after surgery.
Metabolic Parameters, Weight Loss, and Comorbidities 4 Years After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy
Weight loss, reduction in medications for hypertension and diabetes, improvements in markers of diabetes and hyperlipidemia, and remission rates of hypertension were superior with RYGB vs. LSG 4 years post-operatively.
Risk factors for early postoperative complications after bariatric surgery
Recognition and optimization of these risk factors would be valuable in operative risk prediction before bariatric surgery.
Long-term Results of Laparoscopic Sleeve Gastrectomy for Obesity
It appears that after 6+ years the mean excess weight loss exceeds 50%.